Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Endocrine 1

Conditions

Polycystic Ovary Syndrome 1Multiple Endocrine Neoplasia Type 1 1Endometrial Neoplasms 1

Interventions

pembrolizumab 1282Specimen Handling 927Carboplatin 836Magnetic Resonance Spectroscopy 834Cyclophosphamide 807Cisplatin 735Nivolumab 680Paclitaxel 635Radiotherapy 617Gemcitabine 580Biopsy 559Bevacizumab 485Dexamethasone 444fludarabine 410Docetaxel 385venetoclax 372Oxaliplatin 367Capecitabine 361Fluorouracil 357atezolizumab 350durvalumab 340Rituximab 335Drug Therapy 333Radiosurgery 321Doxorubicin 319Blood Specimen Collection 317Standard of Care 311Pemetrexed 307Ipilimumab 303Radiation 287

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Levonorgestrel × 1 year × Clear all
NCT03043924 2025-12-11

MRI-PCOS

University Hospital, Lille

Phase NA Completed
52 enrolled

Polycystic Ovary Syndrome

NCT03455075 2025-10-30

Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men

Premier Research

Phase 2 Completed
92 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT06073184 2025-06-10

WE-FiERCE

University Health Network, Toronto

Phase 2 Not yet recruiting
71 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡